Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

Maschmeyer increases share holding in Biofrontera AG


Print article Print article
Copyright © Thomson Reuters 2013. All rights reserved.
2013-03-25 13:01:57 -

Biofrontera AG /
Maschmeyer increases share holding in Biofrontera AG
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement. 

Leverkusen, 25 March 2013 - Dr. Carsten Maschmeyer participated in a capital
increase of Biofrontera AG last year, purchasing 12.5% of the share capital of
Biofrontera. Today he has informed Biofrontera AG that his investment companies
have purchased additional shares at the stock market, up to a share holding of
15.1% (2,437,618 shares). We refer to our obligatory press release according to
§26 of the German Securities Trading Act.

Dr. Maschmeyer has furthermore informed us that he is even more convinced of an
excellent development of Biofrontera's business than last year, and he intends
to keep the shares long-term, both those purchased 
last year and those now, beyond a holding period ending in April 2013 he had agreed to last year. He intends to increase his share holding even further since he is convinced of a positive development. The board of Biofrontera AG specifies that these assumptions and intents are those of Dr. Maschmeyer, and the company is not allowed to comment them. His actions confirm that Dr. Maschmeyer is a reliable and long-term investor for Biofrontera. About Biofrontera AG Biofrontera aims at attending and treating the skin, recognizing the aesthetic needs of a person's visual reflection. Biofrontera is listed in the regulated market of the Frankfurt stock exchange under the symbol B8F and the ISIN DE0006046113. www.biofrontera.com For further information: Prof. Dr. Hermann Lübbert +49 (0)214 876 32 0 +49 (0)214 876 32 90 press@biofrontera.com Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen Germany This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Biofrontera AG via Thomson Reuters ONE [HUG#1687917]


Press Information:




Contact Person:


Disclaimer: © 2014 Thomson Reuters. The press releases or report contained herein is protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Thomson Reuters's, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com